Advanced Parkinson's disease: clinical characteristics and treatment. Part II

Neurologia. 2013 Nov-Dec;28(9):558-83. doi: 10.1016/j.nrl.2013.05.002. Epub 2013 Jul 21.
[Article in English, Spanish]

Abstract

Introduction: Many patients who have had Parkinson's disease (PD) for several years will present severe motor fluctuations and dyskinesias which require more aggressive therapies. The different approaches which are now available include deep brain stimulation of the subthalamic nucleus or medial globus pallidus, subcutaneous infusion of apomorphine, and intestinal infusion of levodopa-carbidopa.

Objective: To define the indications and results for the 3 available therapies for advanced PD.

Development: Exhaustive review of the literature concerning the indications and results of deep brain stimulation, subcutaneous apomorphine infusion and duodenal infusion of levodopa/carbidopa gel to treat patients with advanced Parkinson disease.

Conclusions: Although numerous studies have confirmed the efficacy of the 3 different therapies in advanced PD, there are no comparative studies that would allow us to define the best candidate for each technique.

Keywords: Advanced Parkinson's disease; Deep brain stimulation; Enfermedad de Parkinson avanzada; Estimulación cerebral profunda; Infusión de apomorfina; Infusión intestinal de levodopa-carbidopa; Intestinal levodopa-carbidopa infusion; Subcutaneous apomorphine infusion.

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use
  • Apomorphine / administration & dosage
  • Apomorphine / adverse effects
  • Apomorphine / therapeutic use
  • Cognition Disorders / etiology
  • Cognition Disorders / therapy
  • Deep Brain Stimulation
  • Disease Progression
  • Humans
  • Infusions, Intravenous
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*
  • Parkinson Disease / psychology
  • Parkinson Disease / therapy*
  • Psychotic Disorders / etiology
  • Psychotic Disorders / therapy

Substances

  • Antiparkinson Agents
  • Apomorphine